Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune and Chronic Inflammatory Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06747351
What this trial is testing

Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda 59
Large-scale testing (Phase 3)Study completedNCT01824251
What this trial is testing

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Nihon Pharmaceutical Co., Ltd 49
Not applicableNo Longer AvailableNCT05014724
What this trial is testing

CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
UCB Biopharma SRL
Not applicableUnknownNCT05940922
What this trial is testing

RWE-based Treatment Patterns and Outcomes in CIDP

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barre SyndromeHereditary Amyloidosis
RwHealth 170
Not applicableActive Not RecruitingNCT07254377
What this trial is testing

Design and Validation of Innovative Strategies Based on Dual-Task Approach

Who this might be right for
StrokeMultiple SclerosisParkinson Disease+2 more
I.R.C.C.S. Fondazione Santa Lucia 48
Not applicableEnded earlyNCT05492604
What this trial is testing

Comparison of FEETME® Soles and GAITRITE® Walkway for the Evaluation of Gait Disorders in CIDP.

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
University Hospital, Bordeaux 18
Not applicableStudy completedNCT00727298
What this trial is testing

Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)

Who this might be right for
Arthritis, RheumatoidSpondylitis, AnkylosingArthritis, Psoriatic+2 more
Merck Sharp & Dohme LLC 4,485
Testing effectiveness (Phase 2)Looking for participantsNCT07840326
What this trial is testing

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

Who this might be right for
Primary Progressive Multiple SclerosisPrimary Progressive MSPrimary Progressive Multiple Sclerosis (PPMS)+6 more
Sundance Biosciences, Inc. 20
Not applicableUnknownNCT03452735
What this trial is testing

Fertility Study of Women With Chronic Inflammatory Rheumatism

Who this might be right for
Arthritis, PsoriaticArthritis, RheumatoidAnkylosing Spondylitis+1 more
University Hospital, Toulouse 2,900
Large-scale testing (Phase 3)Study completedNCT00964210
What this trial is testing

Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination

Who this might be right for
Cervical Cancer
Murdoch Childrens Research Institute 240
Large-scale testing (Phase 3)Study completedNCT02296424
What this trial is testing

SS-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (SJIA)
Novartis Pharmaceuticals 182
Not applicableLooking for participantsNCT07154524
What this trial is testing

Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
University of Ulm 140
Not applicableStudy completedNCT04786431
What this trial is testing

Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases

Who this might be right for
BiomarkerLipidInflammation+4 more
Universidade Nova de Lisboa 427
Early research (Phase 1)Looking for participantsNCT03759522
What this trial is testing

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

Who this might be right for
FibromyalgiaChronic Fatigue SyndromeMultiple Sclerosis+1 more
University of Alabama at Birmingham 120
Not applicableStudy completedNCT04655612
What this trial is testing

Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

Who this might be right for
COVID-19SARS-CoV InfectionRheumatoid Arthritis+3 more
University Hospital, Montpellier 5,000
Not applicableLooking for participantsNCT06968975
What this trial is testing

Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

Who this might be right for
Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi 200
Not applicableLooking for participantsNCT04334031
What this trial is testing

Deployment o the Multidisciplinary Prospective Cohort Imminent

Who this might be right for
Chronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more
University Hospital, Lille 2,200
Testing effectiveness (Phase 2)Study completedNCT00392951
What this trial is testing

Sirolimus for Autoimmune Disease of Blood Cells

Who this might be right for
Autoimmune PancytopeniaAutoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome+6 more
Children's Hospital of Philadelphia 30
Early research (Phase 1)Study completedNCT01398475
What this trial is testing

A Relative Bioavailability and Food Effect Study of New Formulations

Who this might be right for
Chronic Inflammatory DisorderArthritis, Rheumatoid
Eli Lilly and Company 15
Testing effectiveness (Phase 2)UnknownNCT05877040
What this trial is testing

A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Istituto Clinico Humanitas 20
Next Page